Two things happen to SpaceX this week.

This afternoon, after the close, the largest listing in history reports quarterly results as a public company for the first time. On Thursday, 911.5 million shares come free — the first tranche of a lock-up release schedule that runs to fifteen separate dates.

The company priced at $135 in June. It closed last night at $114.53 — fifteen percent below the offer, and roughly half its all-time high of $225.64. It reached that low on the way there: an all-time low of $104.83 yesterday morning, before closing up almost six percent on the day.

Roughly $104 billion of stock is arriving into a tradeable pool worth around $73 billion. Supply at nearly one and a half times the entire float.

That is worth watching on its own. But it is not why this belongs in your inbox.

This is not a story about SpaceX, and it is not a story about whether the stock is cheap. It is a story about what happens when a price was never really discovered — and about whether the comparables holding up your own valuation were.

And for every company still hoping to price this year, one question hangs over it. When the largest listing in history trades below its offer, does the window start to close?

Start with what the underwriters actually did, because the easy accusation is the wrong one.

The deal priced at $135 and opened at $150. By the conventional test — a modest first-day pop, not much money left on the table — that was close to right. Then the stock ran to $225.64 inside a week. No underwriter controls that, and no book-building process could have predicted it.

What happened next was structural, not analytical.

SpaceX floated under five percent of its shares. Shortly after listing, it was added to the Nasdaq 100 — which obliged every fund tracking that index to buy, into a supply of stock that barely existed. Ninety-five percent of the company was locked. Demand was enormous and the tradeable quantity was tiny, and the price did what prices do under those conditions.

So the three numbers in this story are three different things:

$135 was an estimate of value. Negotiated, defensible, arrived at the way these things normally are.

$225.64 was an artifact of scarcity. It was not a judgment about satellite economics or launch cadence. It was the mechanical consequence of forced buying meeting a float that could not supply it.

$114.53 is the market pricing the company for the first time. With more shares available, a real quantity to trade against, and no index rebalancing doing the work.

Nobody got the number wrong. The structure made it impossible to find out what the number was.

Tonight is the other half of it. Until now, SpaceX’s financials have been a snapshot — disclosed once, in a prospectus, as a static picture of a private company. The first quarterly report is a different instrument. It is the first time the trajectory is visible, the first time management’s numbers can be tested against a quarter they actually delivered, and the first time the segment picture has to be laid out for people who can act on it.

For a finance audience the interesting question is not the headline figure but the presentation. A profitable, cash-generative satellite business sits inside the same reporting entity as a heavily loss-making AI operation. How those two are disclosed alongside one another — what gets segmented, what gets aggregated, what the commentary emphasises — will do more to shape the multiple than the revenue line will.

Plenty of companies carry one excellent segment and one expensive one. Very few have to explain it publicly for the first time.

Now the structure reverses. Thursday’s tranche is the first of fifteen scheduled release dates that lift the float toward forty percent by December. A second tranche of 455.8 million shares is gated — it releases only if the stock holds above $175.50 for five of ten consecutive trading days. From where the stock sits this morning, that gate is not close.

Whether Thursday actually moves the price is a separate question from whether the structure was sound. The release schedule has been public since the prospectus, so a case exists that the drift from $225 already reflects it. Anticipating supply and absorbing it are not the same thing — but that is a question the market answers, not one we will.

Demand was never the problem here. The book was oversubscribed, the index buying was real, and the appetite for a large, well-known name was demonstrably there. What failed was the supply architecture. A company floating a conventional fifteen or twenty percent is not running the same experiment, and should not read this chart as a verdict on investor appetite.

But it will be pricing into a market that has just watched this happen. Expect harder questions about float size, more scrutiny of lock-up structure, and rather less patience for index inclusion presented as a demand story. The window is not closing. The terms of getting through it are being renegotiated, and the companies still hoping to price this year will feel that in the room long before they feel it in the book.

Our take: a valuation built on artificial scarcity is not a valuation. It is a queue. Everyone in it is holding a number that was set by how few shares were available, not by what the business is worth. When the queue clears, the number gets tested — and the test arrives on a schedule that was published in the prospectus.

The Fed held last Wednesday, leaving the target range unchanged for the fifth consecutive meeting. Chair Warsh offered little direction, but no ambiguity on the goal: the target stays at 2%, and five years above it will not be cured by a single month of softer prices. Three voters dissented in favour of a hike.

The scorecard. Going into the meeting, futures priced better than one-in-three odds of a hike. We asked you. Of the 61 readers who voted, 77% said the next move would not come last week.

You were right. The curve was not.

That call is not finished, though. Only 23% of you said it would come last week, which means three of the four positions on the board are still live: 31% said no move at all this year, 25% said September, 21% said later in 2026. And the September question moved in a direction almost nobody expected. Going into that meeting, futures priced the odds of a rate above today’s by September near eighty percent. After a hold with three hawkish dissents — the most divided vote since 2016 — those odds eased to 62.7%, even as the 30-year Treasury yield pushed to its highest level since 2007.

Note where that leaves you. Taken together, 48% of you expect a move by September. The market says 62.7%. You are still the more dovish side of that trade.

We will keep the tally.

Tax season doesn't have to mean wondering if you have the right forms, second-guessing your deductions, or scrambling to pull everything together before the deadline.

With BELAY’s tax prep support, you can approach tax season with confidence. Stay organized with one centralized place to gather and check off your documents, keep track of valuable deductions like HSA contributions and education expenses while leaning on experienced professionals who make tax preparation accurate, efficient, and completely hands-off.

Download BELAY's free Personal Tax Checklist and start preparing with confidence, today.

Download the Free Checklist

Four things every CFO needs to know this week.

The SEC wants to shrink the filer population, and the number is larger than it sounds. The Commission’s proposal to collapse five filer categories into two would raise the large accelerated filer threshold from $700 million in public float to $2 billion. By the SEC’s own estimate, the expanded non-accelerated filer category would cover roughly 81% of domestic registrants — up from about 52% today — while representing only around 6.5% of total market float. Non-accelerated filers do not require an auditor attestation on internal control. The comment period closed on July 20. We will cover what it means for your company next week.

A footnote standard with a January deadline nobody is treating as one. FASB’s disaggregation requirement takes effect for annual periods beginning after December 15, 2026 — the FY2027 10-K for calendar-year companies, filed in early 2028. That sounds distant. The data collection starts January 1, and you cannot retroactively disaggregate expenses your general ledger never tagged. If your chart of accounts does not currently split employee compensation across cost of sales, SG&A and R&D, that is a systems project, not a disclosure project.

Private equity is not slowing down. It is concentrating. First-half deal count fell sharply against 2025 while aggregate value rose — sponsors are doing fewer, larger transactions. Meanwhile corporate M&A in the Americas has run up substantially year to date. Strategic buyers are taking share from financial ones, and the reason is on the other side of the ledger: the sponsor exit backlog is at a record, with thousands of portfolio companies held five years or longer.

Boards are increasingly reaching for a temporary answer. Interim appointments accounted for 12% of new CFO hires in the first quarter, double the 6% share a year earlier, according to Russell Reynolds Associates — and in a separate survey of interim finance chiefs in the US and UK, only about a third converted into the permanent seat. Adyen’s move this month to name an insider as interim finance chief while continuing a global search is the pattern in miniature. If your succession plan assumes a clean handover, it is worth checking whether your board would actually reach for one.

SpaceX is an extreme case. The mechanism is not. The first five questions apply whether or not you are public. The sixth is for those of you looking at a listing.

1. What is the actual float on your comparables? Not market capitalisation — tradeable shares. A company with a small public float and a large index following is producing a price that reflects scarcity as much as fundamentals. If two of your five comps are in that position, your multiple range is built on it.

2. Was any of it index-driven? Passive inclusion is a demand event with no view on the business. Check whether your benchmark names were added to a major index in the period you are drawing your multiple from.

3. When do their lock-ups clear? For any recently listed comparable, the release schedule is in the prospectus and it is public. A multiple drawn from a pre-lock-up window is a multiple drawn from an incomplete market.

4. What is your 409A actually built on? If the valuation firm used public comparables, ask which ones and over what window. A defensible 409A built on distorted inputs is still built on distorted inputs — and it is your board that carries the consequence.

5. Would your number survive a bottom-up rebuild? Take the comparables away. Build the valuation from your own unit economics, contribution margin and growth rate. If the two numbers are far apart, you have learned something worth knowing before an investor learns it for you.

6. And if you are planning to list — what float are you actually planning? A small float is tempting: less dilution, more control, and scarcity does flattering things to the opening price. SpaceX is the demonstration of what that buys and what it costs. Two things to test, and neither is the date. Whether your target valuation is anchored to comparables that were themselves priced by scarcity. And whether the float you have been planning survives contact with bankers who have just watched this happen.

SPONSOR THIS NEWSLETTER

Your name, in front of 90,000+ CFOs and senior finance leaders, every Tuesday. The primary slot is available for Q4. Write to [email protected].

Seven weeks ago, in our first issue, we wrote about SpaceX’s debut and asked whether your finance function could pass S-1 scrutiny in ninety days. The window, we said, was not opening. It was open.

It still is. But what it costs to walk through it is being repriced in real time, and the next company to try will tell us by how much.

One question before you go: which of these lists first?

One click. And if you have a view on why, reply — we read everything.

The Editors hold no position in SpaceX.

— The CFO Desk
[email protected] · thecfodesk.com
CAPITAL · FINANCE · LEADERSHIP